Table 1.
Study | Pain Condition |
Sensitivity, % | Specificity, % | Manuscript N | Biomarker Type |
Manuscript Base Rate, % |
Manuscript PPV, % |
Manuscript NPV, % |
Epi Base Rate, % |
Epi PPV, % |
Epi NPV, % |
Clinical PPV, % |
Clinical NPV, % |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Labus et al14 | IBS | 65 | 75 | 160 | Structural MRI | 50 | 72 | 68 | 3–208 | 7–39 | 90–98.5 | 96 | 19 |
Ung et al22 | cLBP | 76 | 75 | 94 | Structural MRI | 50 | 75 | 76 | 1213 | 29 | 96 | 96 | 26 |
Baliki et al3 | cLBP | 91 | 92 | 130 | Structural MRI | 28 | 82 | 96 | 1213 | 61 | 99 | 99 | 54 |
CRPS | 94 | 96 | 22 | 88 | 98 | .214 | 5 | 99 | 99 | 64 | |||
OA | 75 | 95 | 22 | 81 | 93 | 1210 | 67 | 97 | 99 | 30 | |||
Callan et al7 | cLBP | 92 | 92 | 26 | Functional MRI | 50 | 92 | 92 | 1213 | 61 | 99 | 99 | 57 |
Abbreviations: Epi, epidemiological; IBS, irritable bowel syndrome; CRPS, complex regional pain syndrome; OA, osteoarthritis.
NOTE. The bold data represent the markers’ predictive value with the epidemiological and clinical base rates.